91 related articles for article (PubMed ID: 2500181)
1. PET scanning.
Miles KA
BMJ; 1989 Apr; 298(6681):1177. PubMed ID: 2500181
[No Abstract] [Full Text] [Related]
2. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.
Kinahan PE; Hasegawa BH; Beyer T
Semin Nucl Med; 2003 Jul; 33(3):166-79. PubMed ID: 12931319
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response.
Truong MT; Viswanathan C; Erasmus JJ
J Thorac Imaging; 2011 May; 26(2):132-46. PubMed ID: 21508735
[TBL] [Abstract][Full Text] [Related]
4. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
[TBL] [Abstract][Full Text] [Related]
5. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma.
Cerfolio RJ; Ojha B; Mukherjee S; Pask AH; Bass CS; Katholi CR
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):938-44. PubMed ID: 12698159
[TBL] [Abstract][Full Text] [Related]
7. [Should PET scanning be used in lung cancer?].
Højgaard L
Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1074. PubMed ID: 15114379
[No Abstract] [Full Text] [Related]
8. Scanning the scans: comparing CT, MRI, and PET scans.
Harv Mens Health Watch; 2004 Jul; 8(12):3-6. PubMed ID: 15273064
[No Abstract] [Full Text] [Related]
9. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.
Mac Manus MP; Hicks RJ; Matthews JP; McKenzie A; Rischin D; Salminen EK; Ball DL
J Clin Oncol; 2003 Apr; 21(7):1285-92. PubMed ID: 12663716
[TBL] [Abstract][Full Text] [Related]
10. 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma.
Port ER; Yeung H; Gonen M; Liberman L; Caravelli J; Borgen P; Larson S
Ann Surg Oncol; 2006 May; 13(5):677-84. PubMed ID: 16538409
[TBL] [Abstract][Full Text] [Related]
11. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF; ChangLai SP; Chieng PU
Ann Otol Rhinol Laryngol; 2000 Dec; 109(12 Pt 1):1130-4. PubMed ID: 11130825
[TBL] [Abstract][Full Text] [Related]
13. Functional PET scanning in the assessment of cerebral arteriovenous malformations. Case report.
Leblanc R; Meyer E
J Neurosurg; 1990 Oct; 73(4):615-9. PubMed ID: 2398392
[TBL] [Abstract][Full Text] [Related]
14. Hybrid PET/CT machines: optimized PET machines for the new millennium?
Akhurst T; Chisin R
J Nucl Med; 2000 May; 41(5):961-3. PubMed ID: 10809216
[No Abstract] [Full Text] [Related]
15. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
[TBL] [Abstract][Full Text] [Related]
16. [Value of 18F-fluorodeoxyglucose positron emission tomography imaging in staging of non-small cell lung cancer].
Guan Y; He S; Dong J
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1180-3. PubMed ID: 11769705
[TBL] [Abstract][Full Text] [Related]
17. [Role of positron emission tomography in detecting recurrent epithelial ovarian carcinoma].
Zhu X; Shen K; Lang J; Wu M; Huang H; Pan L
Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):356-8. PubMed ID: 12126572
[TBL] [Abstract][Full Text] [Related]
18. Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer.
Zimmer LA; McCook B; Meltzer C; Fukui M; Bascom D; Snyderman C; Townsend DW; Johnson JT
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):178-84. PubMed ID: 12601311
[TBL] [Abstract][Full Text] [Related]
19. Respiration-induced attenuation artifact at PET/CT: technical considerations.
Goerres GW; Burger C; Kamel E; Seifert B; Kaim AH; Buck A; Buehler TC; Von Schulthess GK
Radiology; 2003 Mar; 226(3):906-10. PubMed ID: 12616024
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography in cancer research and treatment.
Mandelkern M; Raines J
Technol Cancer Res Treat; 2002 Dec; 1(6):423-39. PubMed ID: 12625770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
